Tjoa S, Wenger D A, Fennessey P V
Department of Pediatrics, University of Colorado Health Sciences Center, Denver 80262.
J Inherit Metab Dis. 1990;13(2):187-94. doi: 10.1007/BF01799685.
Until recently, there have not been any confirmed reports of beta-mannosidase deficiency in man. We have now analysed urine from two patients with confirmed beta-mannosidase deficiency and have found Man-beta(1-4)GlcNAc concentrations of 65 and 73 mg/mmol creatinine. These levels are at least 12 times higher than those found in patients with other lysosomal storage diseases. The method we report for this analysis requires only 0.1 ml of urine and uses a gas chromatograph, area ratio, calibration curve for the quantitative analysis.
直到最近,尚无关于人类β-甘露糖苷酶缺乏症的确切报道。我们现已分析了两名确诊为β-甘露糖苷酶缺乏症患者的尿液,发现β-(1-4)-N-乙酰氨基葡萄糖(Man-β(1-4)GlcNAc)的浓度分别为65和73毫克/毫摩尔肌酐。这些水平至少比其他溶酶体贮积病患者的水平高12倍。我们报告的这种分析方法仅需0.1毫升尿液,并使用气相色谱仪、面积比和校准曲线进行定量分析。